NCT00047580已完成3 期
A Multicenter, Open-Label, Randomized, 4-Way Crossover Trial of the Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex (Tizanidine Hydrochloride) Tablets Taken Under Fed and Fasted Conditions in Patients With Moderate to Severe Spasticity
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 120
- 试验地点
- 31
研究概览
简要总结
This study is being conducted to compare the impact of somnolence (sleepiness) on cognition (awareness) as well as the safety and effectiveness of tizanidine hydrochloride capsules versus Zanaflex® (tizanidine hydrochloride tablets) taken while in the fed state (just after a meal) and in the fasted state (before a meal) in patients with moderate to severe spasticity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •IRB approved ICF must be signed and dated by patient or patient's legal representative
- •Male or Female 18 years of age or older
- •Clinical diagnosis of established spasticity (at least 3 months) secondary to multiple sclerosis, stroke, or spinal cord injury
- •Currently on stable dose of up to 36mg of Zanaflex
- •Must be able to swallow tablets or capsules whole
排除标准
- •Patients with dementia, aphasia, or other deficits in cognition
- •Unwilling or unable to complete cognition test or daily diary
- •Known sensitivity to Zanaflex
- •Taking Zanaflex on an as needed ("prn") basis
- •Currently being treated with drugs having significant effects at the alpha2 receptors whether agonist (i.e., clonidine, methyldopa) or antagonist (i.e., phenothiazines, imipramine)
- •Currently on any other muscle relaxant or any drugs having muscle relaxant properties (including baclofen, dantrolene, diazepam and other benzodiazepines, tranquilizers, narcotic analgesics, high dose neuroleptics, chlormezanone, meprobamate, methocarbamol, orphenadrine, carisoprodol, gabapentin and clonidine
- •Taking any over-the-counter or prescription sleep aids within 30 days prior to screening
- •Use of illegal drugs or legal drugs for recreational purposes or excessive use of alcohol
- •Patients suffering from disabling, symptomatic hypotension (i.e., syncope)
- •Patients having any systemic disease such as renal insufficiency, clinically relevant elevations in hepatic transaminase, severe, uncontrolled systemic hypertension
- •Any clinically significant illnesses, within four weeks of screening
- •Patients with known sleep disorders
- •Patients who participated in a clinical trial within thiry days prior to screening
- •Women of childbearing potential who are pregnant, have a positive serum pregnancy test, lactating, or do not or will not take adequate contraceptive precautions for the duration of trial
研究者
研究点 (31)
Loading locations...
相似试验
已完成
2 期
A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary InsomniaSleep Initiation and Maintenance DisordersNCT00650871GlaxoSmithKline48
已完成
不适用
A Naturalistic Study Investigating Sleep and Cognitive Learning in Children With and Without Tic DisordersTic DisordersNCT02676492King's College London32
终止
4 期
Sleep Efficiency Assessed by Polysomnography (PSG Sleep Lab Testing) in Advanced Parkinson's DiseaseAdvanced Idiopathic Parkinson's DiseaseNCT01519882UCB Pharma SA1
尚未招募
不适用
To determine effect of sleep quality on mental functions or abilities in individuals having spinal cord injuryCTRI/2022/04/042011ot applicable
已完成
不适用
Sleepiness and Sleep-disordered Breathing in Fabry Disease. A Prospective Cohort Study.Fabry DiseaseNCT01947634University of Zurich52